JSM 2012 Home

JSM 2012 Online Program

The views expressed here are those of the individual authors and not necessarily those of the JSM sponsors, their officers, or their staff.

Online Program Home

Activity Details

471 * Wed, 8/1/2012, 8:30 AM - 10:20 AM CC-Room 23B
Innovations in Design and Analysis of Clinical Trials — Contributed Papers
Biopharmaceutical Section
Chair(s): Chava Zibman, FDA
8:35 AM Random Forest with Regression in the Nodes Georgiy Bobashev, RTI International ; Barry Eggleston, RTI International ; Nikhil Garge, RTI International
8:50 AM Parametric Models for MRI Count Data in Multiple Sclerosis Clinical Trials: A Robustness Study Mallikarjuna Rettiganti, University of Arkansas for Medical Sciences ; Haikady Nagaraja, The Ohio State University
9:05 AM Analytical Methodologies for Clinical Endpoint Data with Excessive Zero Nancy Liu, Merck ; Amarjot Kaur, Merck Research Laboratories ; Jing Li, Merck ; Ziliang Li, Merck
9:20 AM Oracle, Robust, and Best Linear Model Average Estimation in Randomized Trial Kwun Chuen Chan, University of Washington
9:35 AM Global Summary of Treatment Impact Using Multiple Patient Outcomes Brian Claggett, Harvard University ; Lu Tian, Stanford University ; Sihai Dave Zhao, Harvard School of Public Health ; Lee-Jen Wei, Harvard University
9:50 AM Power Analysis for Testing Treatment Effect with a Covariate and a Covariate-Dependent Stratification Factor Chii-Dean Lin, San Diego State University ; Tao Lin, Allergon ; Chien-Feng Chen, Otsuka Pharmaceutical ; Larry Shen, Amylin Pharmaceutical
10:05 AM A Hybrid Bootstrap Approach to Interim Analyses of Time-to-Event Data Using Kaplan-Meier Methods Kevin Lawson, PPD ; Aaron C Camp, PPD ; Austin L Hand, PPD

2012 JSM Online Program Home

For information, contact jsm@amstat.org or phone (888) 231-3473.

If you have questions about the Continuing Education program, please contact the Education Department.